Pierre-Yves Oehrli, Author at Greater Geneva Bern area - Page 33 of 57

Data protection Impressum

Bcomp, a global leader in natural fiber composites, has successfully raised CHF 36 million in a Series C funding round led by EGS Beteiligungen AG.

Bcomp secures CHF 36 million to advance eco-friendly composite materials in mobility

23 April 2024

Swiss4, a Geneva-based fintech established in 2020, has launched an innovative new application, blending financial services with premium lifestyle management.

Geneva’s Swiss4 launches an app merging financial and lifestyle services

22 April 2024

Isospec Analytics, a Vaud-based start-up specializing in biomolecular analysis, has secured USD 1.9 million in pre-seed funding to advance its revolutionary diagnostic technologies.

Isospec pioneers rapid diagnostic technologies with USD 1.9 million funding

22 April 2024

This initiative reflects a broader shift towards life sciences, driven by innovation and a commitment to health, wellness, and sustainability.

The HES-SO strengthens life sciences education and research in the canton of Valais

22 April 2024

Symbio commits CHF 12 million to establish a high-tech hydrogen research center in Corminboeuf, aiming for a 2026 launch.

Symbio invests CHF 12 million in new research facility in Corminboeuf

16 April 2024

MeduSoil’s project seeks to rethink the handling of demolition and excavation waste in Switzerland through the development of a comprehensive recycling and bio-mineralization facility.

MeduSoil embarks on a sustainable construction project in the canton of Vaud

16 April 2024

Backed by a significant Venture Kick investment, bernese start-up Kidemis harnesses innovative technology to revolutionize sustainable aquaculture.

Kidemis secures funds to make aquafarming more sustainable

16 April 2024

French industrial performance specialist OPEO has celebrated the launch of its first international subsidiary at EPFL’s SwissTech Convention Center.

OPEO has officially launched its first international subsidiary in Lausanne

16 April 2024

Vaud-based biopharma Oculis has secured USD 59 million to extend operations into 2026, following a successful listing on NASDAQ Iceland Main Market.

Oculis announces completion of oversubscribed USD 59 million registered direct offering

15 April 2024

Swibrace, in partnership with the Inselspital in Bern, moves its customized wrist braces into clinical phase, enhancing fracture treatment through 3D printing.

Swibrace advances to clinical phase with innovative 3D-printed wrist braces

15 April 2024

1 … 29 30 31 32 33 34 35 36 37 … 57